Annals of Diagnostic Pathology
Volume 12, Issue 1 , Pages 4-11 , February 2008

Basaloid carcinoma of the breast: a review of 9 cases, with delineation of a possible clinicopathologic entity

Presented in part at the 94th Meeting of the United States and Canadian Academy of Pathology, San Antonio, Tex, March 2005.

  • Janez Lamovec, MD

      Affiliations

    • Department of Pathology, Institute of Oncology, SI-1000 Ljubljana, Slovenia
    • ,
  • Giovanni Falconieri, MD

      Affiliations

    • Department of Pathology and Laboratory Medicine, Division of Anatomic Pathology, General Hospital S. Maria della Misericordia, I 33100 Udine UD, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 0432 552826; fax: +39 0432 552830.
    • ,
  • Tiziana Salviato, MD

      Affiliations

    • Department of Pathology, Centro di Riferimento Oncologico, I-33081 Aviano PN, Italy
    • ,
  • Stefano Pizzolitto, MD

      Affiliations

    • Department of Pathology and Laboratory Medicine, Division of Anatomic Pathology, General Hospital S. Maria della Misericordia, I 33100 Udine UD, Italy

References 

  1. Anthony PP, James PD. Adenoid cystic carcinoma of the breast: prevalence, diagnostic criteria, and histogenesis. J Clin Pathol. 1975;28:647–655
  2. Abd El-Rehim DM, Ball G, Pinder SE, et al. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer. 2005;116:340–350
  3. Jones C, Nonni AV, Fulford L, et al. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. Br J Cancer. 2001;85:422–427
  4. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–752
  5. Shin SJ, Rosen PP. Solid variant of mammary adenoid cystic carcinoma with basaloid features: a study of nine cases. Am J Surg Pathol. 2002;26:413–420
  6. Nadji M, Morales AR. Immunohistochemical techniques. In:  Silverberg SG editors. Principles and practice of surgical pathology. New York, NY: Churchill Livingstone; 1990;p. 103–118
  7. Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol. 2006;19:264–271
  8. Lamovec J, Us-Krasovec M, Zidar A, et al. Adenoid cystic carcinoma of the breast: a histologic, cytologic, and immunohistochemical study. Semin Diagn Pathol. 1989;6:153–164
  9. Abd El-Rehim DM, Pinder SE, Paish CE, et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol. 2004;203:661–671
  10. Malzahn K, Mitze M, Thoenes M, et al. Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas. Virchows Arch. 1998;433:119–129
  11. Wetzels RH, Kuijpers HJ, Lane EB, et al. Basal cell–specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol. 1991;138:751–763
  12. Bocker W, Moll R, Poremba C, et al. Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab Invest. 2002;82:737–746
  13. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869–10874
  14. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100:8418–8423
  15. Bryan BB, Schnitt SJ, Collins LC. Ductal carcinoma in-situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Pathol. 2006;19:617–621
  16. Damiani S, Riccioni L, Pasquinelli G, et al. Poorly differentiated myoepithelial cell rich carcinoma of the breast. Histopathology. 1997;30:542–548
  17. Korsching E, Packeisen J, Agelopoulos K, et al. Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab Invest. 2002;82:1525–1533
  18. Tsuda H, Takarabe T, Hasegawa F, et al. Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am J Surg Pathol. 2000;24:197–202
  19. Arpino G, Clark GM, Mohsin S, et al. Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome. Cancer. 2002;94:2119–2127
  20. Cavanzo FJ, Taylor HB. Adenoid cystic carcinoma of the breast. An analysis of 21 cases. Cancer. 1969;24:740–745
  21. Foschini MP, Eusebi V. Carcinomas of the breast showing myoepithelial cell differentiation. A review of the literature. Virchows Arch. 1998;432:303–310
  22. Loose JH, Patchefsky AS, Hollander IJ, et al. Adenomyoepithelioma of the breast. A spectrum of biologic behavior. Am J Surg Pathol. 1992;16:868–876
  23. Page DL. Adenoid cystic carcinoma of breast, a special histopathologic type with excellent prognosis. Breast Cancer Res Treat. 2005;93:189–190
  24. Sinn HP, Lehnert T, Otto HF. Adenoid cystic cancer of the breast. Case report and meta-analysis of the literature. Chirurg. 1993;64:198–202
  25. Van Hoeven KH, Drudis T, Cranor ML, et al. Low-grade adenosquamous carcinoma of the breast. A clinocopathologic study of 32 cases with ultrastructural analysis. Am J Surg Pathol. 1993;17:248–258
  26. Sternlicht MD, Barsky SH. The myoepithelial defense: a host defense against cancer. Med Hypotheses. 1997;48:37–46
  27. Sternlicht MD, Kedeshian P, Shao ZM, et al. The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res. 1997;3:1949–1958
  28. Sternlicht MD, Safarians S, Rivera SP, et al. Characterizations of the extracellular matrix and proteinase inhibitor content of human myoepithelial tumors. Lab Invest. 1996;74:781–796
  29. Batsakis JG, el-Naggar AK. Myoepithelium in salivary and mammary neoplasms is host-friendly. Adv Anat Pathol. 1999;6:218–226
  30. Korsching E, Packeisen J, Liedtke C, et al. The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?. J Pathol. 2005;206:451–457
  31. Tsuda H, Tani Y, Weisenberger J, et al. Frequent KIT and epidermal growth factor receptor overexpressions in undifferentiated-type breast carcinomas with ‘stem-cell–like’ features. Cancer Sci. 2005;96:333–339
  32. Azoulay S, Lae M, Freneaux P, et al. KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome. Mod Pathol. 2005;18:1623–1631
  33. Shin SJ, DeLellis RA, Ying L, et al. Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol. 2000;24:1231–1238
  34. Hoang MP, Maitra A, Gazdar AF, et al. Primary mammary small-cell carcinoma: a molecular analysis of 2 cases. Hum Pathol. 2001;32:753–757
  35. Papotti M, Gherardi G, Eusebi V, et al. Primary oat cell (neuroendocrine) carcinoma of the breast. Report of four cases. Virchows Arch A Pathol Anat Histopathol. 1992;420:103–108
  36. Cubilla ALW, J. M. Woodruff. Primary carcinoid tumor of the breast. A report of eight patients. Am J Surg Pathol. 1977;1:283–292
  37. Azzopardi JG, Muretto P, Goddeeris P, et al. ‘Carcinoid’ tumours of the breast: the morphological spectrum of argyrophil carcinomas. Histopathology. 1982;6:549–569
  38. Ellis GL, Wiscovitch JG. Basal cell adenocarcinomas of the major salivary glands. Oral Surg Oral Med Oral Pathol. 1990;69:461–469
  39. Ellis GL. Basal cell adenocarcinoma. In:  Barnes L,  Eveson JW,  Reichart P,  Sidransky D editor. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005;p. 229–230
  40. Ide F, Mishima K, Saito I. Small foci of high-grade carcinoma cells in adenoid cystic carcinoma represent an incipient phase of dedifferentiation. Histopathology. 2003;43:604–606
  41. Cheuk W, Chan JK, Ngan RK. Dedifferentiation in adenoid cystic carcinoma of salivary gland: an uncommon complication associated with an accelerated clinical course. Am J Surg Pathol. 1999;23:465–472
  42. Moles MA, Avila IR, Archilla AR. Dedifferentiation occurring in adenoid cystic carcinoma of the tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88:177–180
  43. Nagao T, Gaffey TA, Serizawa H, et al. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Mod Pathol. 2003;16:1265–1272
  44. Leibl S, Gogg-Kammerer M, Sommersacher A, et al. Metaplastic breast carcinomas: are they of myoepithelial differentiation? Immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers. Am J Surg Pathol. 2005;29:347–353
  45. Putti TC, El-Rehim DM, Rakha EA, et al. Estrogen receptor–negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod Pathol. 2005;18:26–35

PII: S1092-9134(07)00016-0

doi: 10.1016/j.anndiagpath.2007.01.009

Annals of Diagnostic Pathology
Volume 12, Issue 1 , Pages 4-11 , February 2008

Article Tools

* Image Usage & Resolution